BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 21521850)

  • 1. Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer.
    Morikawa T; Kuchiba A; Yamauchi M; Meyerhardt JA; Shima K; Nosho K; Chan AT; Giovannucci E; Fuchs CS; Ogino S
    JAMA; 2011 Apr; 305(16):1685-94. PubMed ID: 21521850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status.
    Morikawa T; Kuchiba A; Lochhead P; Nishihara R; Yamauchi M; Imamura Y; Liao X; Qian ZR; Ng K; Chan AT; Meyerhardt JA; Giovannucci E; Fuchs CS; Ogino S
    Cancer Res; 2013 Mar; 73(5):1600-10. PubMed ID: 23442321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival.
    Firestein R; Shima K; Nosho K; Irahara N; Baba Y; Bojarski E; Giovannucci EL; Hahn WC; Fuchs CS; Ogino S
    Int J Cancer; 2010 Jun; 126(12):2863-73. PubMed ID: 19790197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor TP53 expression status, body mass index and prognosis in colorectal cancer.
    Morikawa T; Kuchiba A; Liao X; Imamura Y; Yamauchi M; Qian ZR; Nishihara R; Sato K; Meyerhardt JA; Fuchs CS; Ogino S
    Int J Cancer; 2012 Sep; 131(5):1169-78. PubMed ID: 22038927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMO expression in colorectal cancer: associations with clinical, pathological, and molecular features.
    Li T; Liao X; Lochhead P; Morikawa T; Yamauchi M; Nishihara R; Inamura K; Kim SA; Mima K; Sukawa Y; Kuchiba A; Imamura Y; Baba Y; Shima K; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S; Qian ZR
    Ann Surg Oncol; 2014 Dec; 21(13):4164-73. PubMed ID: 25023548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor expression of calcium sensing receptor and colorectal cancer survival: Results from the nurses' health study and health professionals follow-up study.
    Momen-Heravi F; Masugi Y; Qian ZR; Nishihara R; Liu L; Smith-Warner SA; Keum N; Zhang L; Tchrakian N; Nowak JA; Yang W; Ma Y; Bowden M; da Silva A; Wang M; Fuchs CS; Meyerhardt JA; Ng K; Wu K; Giovannucci E; Ogino S; Zhang X
    Int J Cancer; 2017 Dec; 141(12):2471-2479. PubMed ID: 28856682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis.
    Ogino S; Nosho K; Baba Y; Kure S; Shima K; Irahara N; Toyoda S; Chen L; Kirkner GJ; Wolpin BM; Chan AT; Giovannucci EL; Fuchs CS
    Am J Gastroenterol; 2009 Aug; 104(8):2047-56. PubMed ID: 19513025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.
    Baba Y; Nosho K; Shima K; Goessling W; Chan AT; Ng K; Chan JA; Giovannucci EL; Fuchs CS; Ogino S
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):822-31. PubMed ID: 20200425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers.
    Ogino S; Nosho K; Irahara N; Shima K; Baba Y; Kirkner GJ; Meyerhardt JA; Fuchs CS
    J Clin Oncol; 2009 Sep; 27(27):4591-8. PubMed ID: 19704056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cohort study of p27 localization in colon cancer, body mass index, and patient survival.
    Ogino S; Shima K; Nosho K; Irahara N; Baba Y; Wolpin BM; Giovannucci EL; Meyerhardt JA; Fuchs CS
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1849-58. PubMed ID: 19505918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer.
    Yamauchi M; Lochhead P; Imamura Y; Kuchiba A; Liao X; Qian ZR; Nishihara R; Morikawa T; Shima K; Wu K; Giovannucci E; Meyerhardt JA; Fuchs CS; Chan AT; Ogino S
    Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1142-52. PubMed ID: 23629521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGFBR2 and BAX mononucleotide tract mutations, microsatellite instability, and prognosis in 1072 colorectal cancers.
    Shima K; Morikawa T; Yamauchi M; Kuchiba A; Imamura Y; Liao X; Meyerhardt JA; Fuchs CS; Ogino S
    PLoS One; 2011; 6(9):e25062. PubMed ID: 21949851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer.
    Baba Y; Nosho K; Shima K; Freed E; Irahara N; Philips J; Meyerhardt JA; Hornick JL; Shivdasani RA; Fuchs CS; Ogino S
    Clin Cancer Res; 2009 Jul; 15(14):4665-73. PubMed ID: 19584150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer.
    Hanyuda A; Kim SA; Martinez-Fernandez A; Qian ZR; Yamauchi M; Nishihara R; Morikawa T; Liao X; Inamura K; Mima K; Cao Y; Zhang X; Wu K; Chan AT; Giovannucci EL; Meyerhardt JA; Fuchs CS; Shivdasani RA; Ogino S
    Ann Surg Oncol; 2016 Mar; 23(3):908-17. PubMed ID: 26577117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Utility of Molecular Factors by Age at Diagnosis of Colorectal Cancer.
    McCleary NJ; Sato K; Nishihara R; Inamura K; Morikawa T; Zhang X; Wu K; Yamauchi M; Kim SA; Sukawa Y; Mima K; Qian ZR; Fuchs CS; Ogino S; Meyerhardt JA
    Clin Cancer Res; 2016 Mar; 22(6):1489-98. PubMed ID: 26490308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of β-catenin association with obesity in African Americans with premalignant and malignant colorectal lesions.
    Shokrani B; Brim H; Hydari T; Afsari A; Lee E; Nouraie M; Sherif Z; Ashktorab H
    BMC Gastroenterol; 2020 Aug; 20(1):274. PubMed ID: 32811441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis.
    Inamura K; Yamauchi M; Nishihara R; Lochhead P; Qian ZR; Kuchiba A; Kim SA; Mima K; Sukawa Y; Jung S; Zhang X; Wu K; Cho E; Chan AT; Meyerhardt JA; Harris CC; Fuchs CS; Ogino S
    J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25190725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer.
    Nosho K; Shima K; Irahara N; Kure S; Baba Y; Kirkner GJ; Chen L; Gokhale S; Hazra A; Spiegelman D; Giovannucci EL; Jaenisch R; Fuchs CS; Ogino S
    Clin Cancer Res; 2009 Jun; 15(11):3663-71. PubMed ID: 19470733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical Activity and Colorectal Cancer Prognosis According to Tumor-Infiltrating T Cells.
    Koh H; Hamada T; Song M; Liu L; Cao Y; Nowak JA; da Silva A; Twombly T; Morikawa T; Kim SA; Masugi Y; Kosumi K; Shi Y; Gu M; Li W; Du C; Chen Y; Li W; Liu H; Li C; Wu K; Nosho K; Inamura K; Hanyuda A; Zhang X; Giannakis M; Chan AT; Fuchs CS; Nishihara R; Meyerhardt JA; Ogino S
    JNCI Cancer Spectr; 2018 Oct; 2(4):pky058. PubMed ID: 31276098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer.
    Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Kirkner GJ; Dehari R; Meyerhardt JA; Fuchs CS; Ogino S
    Neoplasia; 2007 Jul; 9(7):569-77. PubMed ID: 17710160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.